Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001331851 | SCV001523991 | likely pathogenic | Polycystic kidney disease 5 | 2019-09-30 | criteria provided, single submitter | clinical testing | This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Prevention |
RCV004754732 | SCV005359282 | likely pathogenic | DZIP1L-related disorder | 2024-03-18 | no assertion criteria provided | clinical testing | The DZIP1L c.727C>T variant is predicted to result in premature protein termination (p.Gln243*). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0064% of alleles in individuals of African descent in gnomAD. Nonsense variants in DZIP1L are expected to be pathogenic. This variant is interpreted as likely pathogenic. |